Bicyklo[4.4.0]dekan. Metoda oznaczania w powietrzu na stanowiskach pracy

Bicyclo[4.4.0]decane (BCD), also known as decalin, is a colorless liquid with the scent of camphor, menthol and naphthalene. This substance can be fatal if swallowed or entered a respiratory tract. It can cause severe skin burns and eye damage, and is toxic if inhaled. The aim of this study was to develop a method for determining BCD in workplace air, which will allow the determination of its concentrations at the level of 5 mg/m3 . The method was based on adsorption of BCD vapors on activated carbon, desorption with acetone solution in carbon disulfide and chromatographic analysis of the obtained solution. The study was performed with a gas chromatograph (GC) with a flame ionization detector (FID) equipped with a DB-VRX capillary column (60 m × 0.25 mm, 1.4 µm). The method was validated in accordance with the requirements of Standard No. EN 482. The method allows the determination BCD in workplace air in the concentration range 5–200 mg/m3 . The method for determining BCD has been recorded in the form of an analytical procedure (see Appendix). This article discusses the problems of occupational safety and health, which are covered by health sciences and environmental engineering.

Autoimmune polyglandular syndrome type 1 and eye damage

Autoimmune polyendocrine syndrome type 1 (APS type 1) is a disease characterized by a variety of clinical manifestations resulting from the involvement of multiple endocrine and non-endocrine organs in the pathological process. APS type 1 is a rare genetically determined disease with autosomal recessive inheritance. Mutations in the autoimmune regulator gene (AIRE) lead to a disruption of the mechanism of normal antigen expression and the formation of abnormal clones of immune cells, and can cause autoimmune damage to organs. Within APS type 1, the most common disorders are primary adrenal insufficiency, hypoparathyroidism, and chronic candidiasis. Some understudied clinical manifestations of APS type 1 are autoimmune pathological processes in the eye: keratoconjunctivitis, dry eye syndrome, iridocyclitis, retinopathy, retinal detachment, and optic atrophy. This review presents the accumulated experimental and clinical data on the development of eye damage of autoimmune nature in APS type 1, as well as the laboratory and instrumental methods used for diagnosing the disease. Changes in the visual organs in combination with clinical manifestations of hypoparathyroidism, adrenal insufficiency and candidiasis should lead the clinical doctor to suspect the presence of APS type 1 and to examine the patient comprehensively. Timely genetic counselling will allow early identifi cation of the disease, timely prescription of appropriate treatment and prevention of severe complications.

Bilateral neurorethinovasculitis associated with COVID-19 infection in a girl 17 years old

Despite dominant lung lesions, new coronavirus infection (COVID-19) can influence almost any organ, including eyes. According to modern data, frequency of eye damage by COVID-19 reaches 32%, and spectrum of clinical manifestations is diverse. Changes are observed both in the anterior (mainly conjunctivitis) and posterior (mostly retinal vascular thrombosis, optic neuritis, neuroretinitis) segments of the eye, and the timing of their occurrence varies from the first (sometimes the only) clinical symptoms of the disease to the development at the peak or during the period of convalescence from COVID-19. In children symptomatic COVID-19 infection is diagnosed less frequently than in adults, and ophthalmic manifestations are less investigated. This article describes a case of bilateral neuroretinovasculitis in a 17-year-old girl with a mild course of COVID-19, that arose 3 weeks after the onset of the disease, which broadens the understanding of ocular manifestations of COVID-19 in children. We emphasize that an ophthalmologist should know ocular manifestations of COVID-19, which can help in the diagnosis and further study of the frequency and spectrum of ophthalmic symptoms, especially in children

Diagnosis of Ophthalmic Diseases in Fundus Image by Using Deep Learning

In the human eye, Damage in the retina may cause ophthalmic diseases like cataracts, AMD, Hypertensive retinopathy, myopia, etc. To cure these diseases, many ophthalmologists use retinal fundus images as an important information source to find out ophthalmic diseases. Multiple techniques have been introduced for the screening of ocular diseases. Today’s world is in great demand to find out ocular diseases by using deep learning and machine learning techniques. This paper uses pre-trained deep neural networks to determine five categories of ophthalmic diseases such as cataract, AMD, Hypertensive retinopathy, myopia, and normal. Dataset is created into binary and multiclass, then trained on Resnet-101 of convolutional neural network (CNN) and evaluated. The accuracy of this model is found to be 90.38% and 88.5% for binary and multiclass respectively. Keywords: Retinal fundus image, Ocular diseases, CNN, ResNet, deep learning. Image processing, Ensemble classifier

Czy promieniowanie optyczne pochodzące z urządzeń rzeczywistości wirtualnej i rozszerzonej może stanowić zagrożenie dla zdrowia?

Virtual reality (VR) and originating augmented reality (AR) devices are increasingly used not only for entertainment purposes, but also as elements supporting training or rehabilitation. Considering the development of this technology in recent years, it can be assumed that in the near future these devices will become part of some workplaces. However, in order to ensure the safety of employees using virtual and augmented reality devices, make sure that they do not pose a threat to human health, and in particular they do not cause eye damage or circadian rhythm disturbances related to optical radiation emitted by displays.

Eye damage due to dental disease

Recently, a lot of space has been given in the literature to the question of oral sepsis; the possibility of disease of any organ and in particular the eye in the presence of an infectious focus of dental origin is considered established by experimental work and clinical observations.

Case report: an unusual unilateral pterygium — a secondary pterygium caused by parasitosis in the scleral fistula

Background Ocular parasitosis can cause eye damage, which contribute to eye symptoms such as burning, itching and even blindness. It is uncommon to see the parasitosis lying in the sclera layer, neither it causing pterygium. Here, we present an unusual case of a secondary pterygium caused by intrascleral worm. Case presentation A 52-year-old women complained about discomfort in right eye for 6 years. Slit-lamp examination indicated a thickened triangular layers of conjunctiva extending from the nasal edge to the cornea. The diagnosis was pterygium in the right eye. To our surprise, after scleral of nasal side exposed, we could see a tiny fistula right in the sclera which lied right under the pterygium, with an alive and motile worm inside. An intrascleral fistula was noted. Then the worm was removed by forceps from the fistula, which was creamy white, thread-like and 1 cm long. Discussion and conclusions As far as we known, it is the first case of an intrascleral worm hidden beneath the conjunctiva which caused the secondary pterygium. It is hard to know the etiology of the secondary pterygium which caused by parasitosis in the scleral fistula untill excision surgery. It is hard to imagine the worm was living in the sclera of the patient for a long-time.

Pilot-Scale Experiences with Aerobic Treatment and Chemical Processes of Industrial Wastewaters from Electronics and Semiconductor Industry

TMAH is quaternary ammonium salt, consists of a methylated nitrogen molecule, and is widely used in the electronics industry as a developer and silicon etching agent. This substance is toxic and fatal if ingested. It can also cause skin burns, eye damage, and organ damage. Moreover, TMAH exhibits long-lasting toxicity to aquatic systems. Despite this known toxicity, the authorities currently do not provide emission limits (i.e., discharge concentrations) for wastewater by EU regulation. The current scenario necessitates the study of the processes for industrial wastewater containing TMAH. This work aims to present a successful example of the treatment process for the degradation of TMAH waste solutions of the E&S industry. Research was conducted at the pilot scale, and the process feasibility (both technical and economic) and its environmental sustainability are demonstrated. This process, which treats three exhausted solutions with a high concentration of toxic substances, is considered to be innovative.